FDA approves PFE’s Epogen/Procrit FoB, Retacrit: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607703.htm The third time is the charm. FDA rejected this 351(k) application in 2017 (#msg-132420191) and 2015 (#msg-118040117).